Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 158

1.

The Nuclear Receptor, RORĪ³, Regulates Pathways Necessary for Breast Cancer Metastasis.

Oh TG, Wang SC, Acharya BR, Goode JM, Graham JD, Clarke CL, Yap AS, Muscat GE.

EBioMedicine. 2016 Apr;6:59-72. doi: 10.1016/j.ebiom.2016.02.028. Epub 2016 Feb 18.

2.

Developing an Algorithm to Identify History of Cancer Using Electronic Medical Records.

Clarke CL, Feigelson HS.

EGEMS (Wash DC). 2016 Apr 13;4(1):1209. doi: 10.13063/2327-9214.1209. eCollection 2016.

3.

Narrative citizenship, resilience and inclusion with dementia: On the inside or on the outside of physical and social places.

Clarke CL, Bailey C.

Dementia (London). 2016 May;15(3):434-52. doi: 10.1177/1471301216639736.

PMID:
27170591
4.

Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Hilton HN, Graham JD, Clarke CL.

Mol Endocrinol. 2015 Sep;29(9):1230-42. doi: 10.1210/me.2015-1152. Epub 2015 Aug 12.

PMID:
26266959
5.

Impact of progesterone on stem/progenitor cells in the human breast.

Hilton HN, Clarke CL.

J Mammary Gland Biol Neoplasia. 2015 Jun;20(1-2):27-37. doi: 10.1007/s10911-015-9339-y. Epub 2015 Aug 8.

PMID:
26254191
6.

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.

Bonneterre J, Hutt E, Bosq J, Graham JD, Powell MA, Leblanc E, Fujiwara K, Herzog TJ, Coleman RL, Clarke CL, Gilles EM, Zukiwski AA, Monk BJ.

Gynecol Oncol. 2015 Sep;138(3):663-7. doi: 10.1016/j.ygyno.2015.06.037. Epub 2015 Jul 2.

PMID:
26142884
7.

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.

Mote PA, Gompel A, Howe C, Hilton HN, Sestak I, Cuzick J, Dowsett M, Hugol D, Forgez P, Byth K, Graham JD, Clarke CL.

Breast Cancer Res Treat. 2015 Jun;151(2):309-18. doi: 10.1007/s10549-015-3397-0. Epub 2015 Apr 28.

PMID:
25917868
8.

Falls research: stumbling or striding?

Clarke CL, McMurdo ME, Witham MD.

Age Ageing. 2015 May;44(3):350-2. doi: 10.1093/ageing/afv047. Epub 2015 Apr 10. No abstract available.

9.

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.

Wong-Brown MW, Meldrum CJ, Carpenter JE, Clarke CL, Narod SA, Jakubowska A, Rudnicka H, Lubinski J, Scott RJ.

Breast Cancer Res Treat. 2015 Feb;150(1):71-80. doi: 10.1007/s10549-015-3293-7. Epub 2015 Feb 15.

PMID:
25682074
10.

Nursing students' attitudes towards information and communication technology: an exploratory and confirmatory factor analytic approach.

Lee JJ, Clarke CL.

J Adv Nurs. 2015 May;71(5):1181-93. doi: 10.1111/jan.12611. Epub 2015 Jan 13.

PMID:
25586107
11.

Biobanking sustainability--experiences of the Australian Breast Cancer Tissue Bank (ABCTB).

Carpenter JE, Clarke CL.

Biopreserv Biobank. 2014 Dec;12(6):395-401. doi: 10.1089/bio.2014.0055.

PMID:
25496151
12.

Bioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer.

Khushi M, Clarke CL, Graham JD.

PeerJ. 2014 Nov 18;2:e654. doi: 10.7717/peerj.654. eCollection 2014.

13.

Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.

Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, Russell P, Kennedy C, Fereday S, Hung J, Galletta L, Hogg R, Wain GV, Brand A, Balleine R, MacConaill L, Palescandolo E, Hunter SM, Campbell I, Dobrovic A, Wong SQ, Do H, Clarke CL, Harnett PR, Bowtell DD, deFazio A; Australian Ovarian Cancer Study (AOCS).

Clin Cancer Res. 2014 Dec 15;20(24):6618-30. doi: 10.1158/1078-0432.CCR-14-1292. Epub 2014 Oct 14.

14.

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.

Hilton HN, Doan TB, Graham JD, Oakes SR, Silvestri A, Santucci N, Kantimm S, Huschtscha LI, Ormandy CJ, Funder JW, Simpson ER, Kuczek ES, Leedman PJ, Tilley WD, Fuller PJ, Muscat GE, Clarke CL.

Oncotarget. 2014 Sep 30;5(18):8651-64.

15.

Organisational space for partnership and sustainability: lessons from the implementation of the National Dementia Strategy for England.

Clarke CL, Keyes SE, Wilkinson H, Alexjuk J, Wilcockson J, Robinson L, Corner L, Cattan M.

Health Soc Care Community. 2014 Nov;22(6):634-45. doi: 10.1111/hsc.12134. Epub 2014 Sep 22.

PMID:
25243927
16.

PRMT2 and RORĪ³ expression are associated with breast cancer survival outcomes.

Oh TG, Bailey P, Dray E, Smith AG, Goode J, Eriksson N, Funder JW, Fuller PJ, Simpson ER, Tilley WD, Leedman PJ, Clarke CL, Grimmond S, Dowhan DH, Muscat GE.

Mol Endocrinol. 2014 Jul;28(7):1166-85. doi: 10.1210/me.2013-1403. Epub 2014 Jun 9.

PMID:
24911119
17.

Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the Literature.

Schwab LC, Luo V, Clarke CL, Nathan PJ.

Curr Neuropharmacol. 2014 May;12(3):281-8. doi: 10.2174/1570159X11666140104001553.

18.

Breast cancer prognosis predicted by nuclear receptor-coregulator networks.

Doan TB, Eriksson NA, Graham D, Funder JW, Simpson ER, Kuczek ES, Clyne C, Leedman PJ, Tilley WD, Fuller PJ, Muscat GE, Clarke CL.

Mol Oncol. 2014 Jul;8(5):998-1013. doi: 10.1016/j.molonc.2014.03.017. Epub 2014 Apr 4.

19.

"We're all thrown in the same boat ... ": A qualitative analysis of peer support in dementia care.

Keyes SE, Clarke CL, Wilkinson H, Alexjuk EJ, Wilcockson J, Robinson L, Reynolds J, McClelland S, Corner L, Cattan M.

Dementia (London). 2014 Apr 17. [Epub ahead of print]

PMID:
24742876
20.

Binding sites analyser (BiSA): software for genomic binding sites archiving and overlap analysis.

Khushi M, Liddle C, Clarke CL, Graham JD.

PLoS One. 2014 Feb 12;9(2):e87301. doi: 10.1371/journal.pone.0087301. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk